• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

CS-Keys

edit

CS-Keys is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer.

Milestones

edit

• 
  CS-Keys received $285k in Venture Round funding. (6/7/06)
  Posted 5/2/10 at 11:53pm via accessmylibrary.com
• 
  CS-Keys received $6.25M in Series A funding. (1/25/08)
  Posted 12/18/09 at 3:41am via ceresventurefund.com

Videos

Screenshots

edit

Above: CS-Keys
Uploaded: 12/18/09

Sources

1. BioCrossroads' Indiana Seed Fund Invests $285,000 in Company Developing Novel Breast Cancer Diagnostic Tool; Technology Developed by CS-Keys Can Detect Cancer in Single Cell. (accessmylibrary.com) [edit]
2. Ceres Venture Fund Invests in $6.25 Million Series A Round for Cancer-Specific Biomarker Company CS-Keys, Inc. (ceresventurefund.com) [edit]